Literature DB >> 19827033

Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates.

Shyh-Ying Chiou1, Chuan-Fu Huang, Mei-Ting Hwang, Gialih Lin.   

Abstract

We have reported that benzene-1,2-, 1,3-, and 1,4-di-N-substituted carbamates (1-15) are characterized as the conformationally constrained inhibitors of acetylcholinesterase and mimic gauche, eclipsed, and anti-conformations of acetylcholine, respectively (J Biochem Mol Toxicol 2007;21:348-353). We further report the inhibition of butyrylcholinesterase by these inhibitors. Carbamates 1-15 are also characterized as the pseudosubstrate inhibitors of butyrylcholinesterase as in the acetylcholinesterase catalysis. Benzene-1,4-di-N-n-hexylcarbamate (12) and benzene-1,4-di-N-n-octylcarbamate (13) are the two most potent inhibitors of butyrylcholinesterase among inhibitors 1-15. These two para compounds, with the angle of 180 degrees between two C(benzene)--O bonds, mimic the preferable anti C--O/C--N conformers for the choline ethylene backbone of butyrylcholine during the butyrylcholinesterase catalysis. The second n-hexylcarbamyl or n-octylcarbamyl moiety of inhibitors 12 and 13 is proposed to bind tightly to the peripheral anionic site of butyrylcholinesterase from molecular modeling. Butyrylcholinesterase prefers para-carbamates to ortho- and meta-carbamates, whereas acetylcholinesterase prefers para- and meta-carbamates to ortho-carbamates. This result implies that the anionic site of butyrylcholinesterase is relatively smaller than that of acetylcholinesterase because meta-carbamates, which may bind to the anionic sites of both enzymes, are not potent inhibitors of butyrylcholinesterase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19827033     DOI: 10.1002/jbt.20286

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  9 in total

1.  In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes.

Authors:  Amal Al-Aboudi; Raed A Al-Qawasmeh; Alaa Shahwan; Uzma Mahmood; Asaad Khalid; Zaheer Ul-Haq
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

2.  Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as conformationally constrained inhibitors of cholesterol esterase.

Authors:  Ming-Cheng Lin; Gin-Zen Lin; Ching-In Hwang; Shuo-Yung Jian; James Lin; Yu-Fong Shen; Gialih Lin
Journal:  Protein Sci       Date:  2012-08-09       Impact factor: 6.725

3.  Catalytic characteristics of plant-esterase from wheat flour.

Authors:  Chang-jun Hou; Kun He; Li-min Yang; Dan-qun Huo; Mei Yang; Shun Huang; Liang Zhang; Cai-hong Shen
Journal:  World J Microbiol Biotechnol       Date:  2011-08-04       Impact factor: 3.312

4.  Understanding the enzyme-ligand complex: insights from all-atom simulations of butyrylcholinesterase inhibition.

Authors:  Walter Alvarado; Parker Ladd Bremer; Angela Choy; Helen N Dinh; Aingty Eung; Jeannette Gonzalez; Phillippe Ly; Trina Tran; Kensaku Nakayama; Jason P Schwans; Eric J Sorin
Journal:  J Biomol Struct Dyn       Date:  2019-04-07

5.  Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents.

Authors:  Sheunopa C Mzezewa; Sylvester I Omoruyi; Luke S Zondagh; Sarel F Malan; Okobi E Ekpo; Jacques Joubert
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

6.  1,3-substituted imidazolidine-2,4,5-triones: synthesis and inhibition of cholinergic enzymes.

Authors:  Vladimir Pejchal; Sarka Stepankova; Zdenka Padelkova; Ales Imramovsky; Josef Jampilek
Journal:  Molecules       Date:  2011-09-05       Impact factor: 4.411

7.  Combined in Vitro and in Silico Studies for the Anticholinesterase Activity and Pharmacokinetics of Coumarinyl Thiazoles and Oxadiazoles.

Authors:  Aliya Ibrar; Ajmal Khan; Majid Ali; Rizwana Sarwar; Saifullah Mehsud; Umar Farooq; Syed M A Halimi; Imtiaz Khan; Ahmed Al-Harrasi
Journal:  Front Chem       Date:  2018-03-26       Impact factor: 5.221

8.  Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking.

Authors:  Ales Imramovsky; Sarka Stepankova; Jan Vanco; Karel Pauk; Juana Monreal-Ferriz; Jarmila Vinsova; Josef Jampilek
Journal:  Molecules       Date:  2012-08-24       Impact factor: 4.411

9.  Design, Synthesis, and Structure-Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer's Disease.

Authors:  Begüm Nurpelin Sağlık; Derya Osmaniye; Ulviye Acar Çevik; Serkan Levent; Betül Kaya Çavuşoğlu; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2020-09-20       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.